News

08/05/2025

Lipid Alterations Linked to Cardiovascular Risk Detected in People with Type 2 Diabetes

A recent study has identified specific alterations in lipid metabolism associated with subclinical atherosclerosis in individuals with type 2 diabetes. This silent condition, known as atherosclerosis,...

07/05/2025

Intravenous Administration of Atorvastatin Protects Against Infarction in the Presence of Diabetic Cardiomyopathy

Intravenous administration of atorvastatin during acute myocardial infarction could become a new therapeutic strategy capable of limiting infarct size in patients with diabetic cardiomyopathy, a heart...

30/04/2025

IR Sant Pau Strengthens Collaboration with Ephion Health and Joins the Startup’s Shareholding

The Sant Pau Research Institute (IR Sant Pau) has formalized a strategic agreement with Ephion Health, a company specialized in developing artificial intelligence technologies for monitoring mobility ...

29/04/2025

Over €100,000 raised for Ewing Sarcoma research at Sant Pau

In November 2023, the charity race L’Arriarem, organized by the family of Marc Riera i Castellà in his memory, raised over €96,000. Thanks to this momentum and all subsequent donations, €101,33...

29/04/2025

A New CAR-T Therapy from Sant Pau Achieves Positive Results in a High Proportion of Patients with a Refractory Type of Lymphoma

Researchers at the Sant Pau Research Institute (IR Sant Pau), in collaboration with the Hospital de Sant Pau and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cel...